| Sr. No. | Title |
|---|---|
| 1 |
A flow cytometry assay and rapid agglutination test for the detection of anti-FVIII antibodies- SERB PI: Dr. Rucha Patil |
| 2 |
Antibody Profile in post- vaccinated individuals when compared to post-COVID-19 patients PI: Dr. Rucha Patil |
| 3 |
Clinical, Immunological and Molecular characterization of an Autoimmune Lymphoproliferative Syndrome (ALPS) and B-cell expansion with NF?? and T- cell anergy(BENTA) in Indian population. PI: Dr. Manisha Madkaikar |
| 4 |
Clinical, Molecular and Cytogenetic Study of Myeloproliferative neoplasms PI: Dr. Babu Rao Vundinti |
| 5 |
Comprehensive immune profiling and its correlation with response to therapy and underlying genetic variations in Immune Thrombocytopenia (ITP). PI: Dr. Manisha Madkaikar |
| 6 |
Defining immunological markers for response to therapy in Aplastic Anemia PI: Dr. Manisha Madkaikar |
| 7 |
Development of G6PD point of care test (ICMR) PI: Dr. Rucha Patil |
| 8 |
Exploring immune players in clinical conditions of HBV infection. PI: Dr. Anindita Banerjee |
| 9 |
Exploring lymphocyte subsets and cytokine profile in Pediatric Inflammatory Multisystem Syndrome temporally related to SARS-CoV-2 infection (PIMS-TS). (Intramural) PI: Dr. Manisha Madkaikar |
| 10 |
ICMR Task force study on Rational Use of Medicines PI: Dr. Manisha Madkaikar |
| 11 |
Identification and molecular characterization of weak D variants among apparently RhD negative individuals from South India (Intramural project in collaboration with JIPMER) PI: Dr. Swati Kulkarni |
| 12 |
Immune response to precautionary third dose of COVISHIELD/COVAXIN among healthy adult population: an ICMR Cohort study, India PI: Dr. Reetika Yadav |
| 13 |
Molecular studies of Keap1-Nrf2 signalling axis in the pathophysiology of Sickle cell disease: an exploratory study PI: Dr. Naga Merugu |
| 14 |
Multi Centric Collaborative Study of the National Registry for Rare Disorders in India- Bleeding disorders PI: Dr. Rucha Patil |
| 15 |
Platelet phenotyping (surface receptors, granules, secretion, and signal transduction) and genotyping of unclassified heritable thrombocytopenia and platelet function disorders. PI: Dr. Bipin Kulkarni |
| 16 |
Role of angiotensin converting enzyme 2 and vitamin D in endothelial dysfunction among COVID-19 patients from Mumbai, Maharashtra PI: Dr. Vandana Pradhan |
| 17 |
Role of Ion Channelopathies in Sickle Cell Disease PI: Dr. Prashant P Warang |
| 18 |
Strengthening of ICMR-MRUs: Establishment of Autoimmune Diagnostic Laboratories for early detection and management of Autoimmune Disease and empowering MRUs for research in autoimmunity PI: Dr. Vandana Pradhan |
| 19 |
Studies on ABO histo?blood group genes and ACE2 as potential genetic susceptibility factors to SARS-CoV-2 infections: an exploratory study PI: Dr. Swati Kulkarni |
| 20 |
Studies on the role of CD47/SIRP?-interaction in regulation of erythrophagocytosis PI: Dr. Naga Merugu |
| 21 |
Study of DNA methylation of Polycomb genes and micro RNAs in Drug Resistance CML patients PI: Dr. Babu Rao Vundinti |
| 22 |
Study of genetic factors and immune parameters focusing on the transmission of HBV in household contacts of classical HBV cases PI: Dr. Anindita Banerjee |
| 23 |
Study of genome wide expression profiling of long non coding RNAs (lncRNAs) and mRNA association with myelodysplastic syndromes pathogenesis PI: Dr. Babu Rao Vundinti |
| 24 |
Study of micro-RNA expression profile in common variable immunodeficiency disorder PI: Dr. Manisha Madkaikar |
| 25 |
Study of molecular pathology of Idiopathic Aplastic Anemia PI: Dr. Babu Rao Vundinti |
| 26 |
Study of the molecular mechanism of bone marrow failure and cancer risk in Fanconi anemia complementation groups PI: Dr. Babu Rao Vundinti |
| 27 |
Study on Polio and Non-Polio enterovirus infections in children withimmunodeficiency at multiple medical institutes across India. Phase II PI: Dr. Manisha Madkaikar |
| 28 |
The role of epigenetic factors in Fanconi anemia phenotype and cancer predisposition PI: Dr. Babu Rao Vundinti |
| 29 |
To study the role of mitochondrial DNA damage due to iron overload in transfusion dependent Thalassemia major PI: Dr. Reetika Yadav |
| 30 |
To study the role of Regulatory T cells in failure to mount an adequate immune response post-Hepatitis B vaccination PI: Dr. Reetika Yadav |
| 31 |
Tranexamic acid combined with recombinant factor VIII for haemophilia patients- (ICMR) PI: Dr. Rucha Patil |
| 32 |
Study on Factors Influencing Implementation of Iron and Folic Acid Supplementation in Pregnant Women under Anaemia Mukt Bharat Program PI: Dr. Amrutha Jose |
| 33 |
Investigating the role of human gut microbiome in sickle cell disease – (Institutional funding) PI: Dr. Chhedi Lal Gupta |
